Roflumilast Tablet
Product Images NDC 60687-786

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Roflumilast (NDC 60687-786). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

500 Mcg Roflumilast Tablet Blister (500 Mcg Roflumilast Tablet Blister)

Image of multiple identical pharmacy labels for Roflumilast 500 mcg oral tablets. Each label includes the product name, strength, barcode, NDC 60687-786-117, and indicates packaging by American Health Packaging, Columbus, Ohio.*

FDA Label Image

500 Mcg Roflumilast Tablets Carton (500 Mcg Roflumilast Tablets Carton)

Label for Roflumilast tablets 500 mcg oral dosage form by American Health Packaging. The label shows a package of 30 tablets (3 x 10) with NDC 60687-786-21. It includes directions for pharmacist dispensing with the medication guide, dosage information, storage instructions, and a QR code for medication guide and prescribing info.*

FDA Label Image

Ahp78621

Roflumilast 500 microgram oral tablet by American Health Packaging shows a small, round, white tablet imprinted with "H" on one side and "I" on the other. The tablet is uncoated and plain in appearance.*

FDA Label Image

Structural Formula (Structure 01)

Chemical structure of Roflumilast, showing its molecular arrangement with fluorine, oxygen, chlorine, nitrogen atoms, and cyclopropyl groups, consistent with the active ingredient Roflumilast.*

FDA Label Image

Figure 1. Effect Of Concomitant Drugs On The Exposure Of Roflumilast And Roflumilast N-oxide. (Figure1)

A chart depicting the fold change in Cmax and AUC with 90% confidence intervals for Roflumilast and its N-oxide metabolite, comparing various drugs' effects. The chart includes recommendations for each drug interaction ranging from 'Use With Caution' to 'No Dose Adjustment' and 'Not Recommended.' The x-axis shows fold changes relative to reference values.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.